It’s time for a listener favorite, the annual Inside Workers’ Comp Thanksgiving special edition: What are You Thankful for in Workers’ Comp? This year, we pose the question to experts who serve three very different facets of the industry: Jim Harris, VP of Analytics and Reporting; Debbi Bromley, Senior VP of Human Resources; and Lisa Armstrong, BSN, CRRN, RN-BC, Catastrophic and Medical Case Manager. We hope their responses lead you to contemplate on your own unique role in workers’ comp and how YOU make a difference in the lives of others.
More stories
Introducing Networks 2.0: Part Two
Treating those hurt on the job makes sense for other reasons as well. The injured worker isn’t responsible for paying a deductible or copay. This is becoming an evermore important differentiator. That’s because out-of-pocket costs can be difficult for patients to manage, especially as many are now expected to shoulder a larger share of the medical expense with the rise of high-deductible commercial plans.
New Account Maintenance Feature Now Available in Mitchell SmartAdvisor Platform
New feature helps improve efficiency, consistency and configurability.
Pam Gore Receives Beverley Boesch Legacy Award
Pot Policies in Workers' Compensation and Auto Casualty [Webinar]
Even as the pandemic takes center stage, marijuana legislation has been makin
Staying Connected During COVID-19
We asked our Field Case Managers how they were staying connected to their injured workers and finding meaning and purpose during the COVID-19 pandemic. Their responses were more than we expected. It warmed our hearts and we were happy to gain a small insight into their lives. We’d like to share their moving and heartfelt video messages with you in a special installment of The Sounding Board blog.
Potential Drug Therapy Treatments for COVID-19: Impact on Workers’ Compensation
As response to the COVID-19 pandemic shifts into new phases—parts of the United States are reopening and businesses and many states are considering how to get people back to work—scientists continue to research potential medications that could be used to treat the disease.